|
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no 67): a systematic review and economic evaluation |
Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no 67): a systematic review and economic evaluation. Health Technology Assessment 2009; 13(11): 1-268 Indexing Status Subject indexing assigned by NLM MeSH Amantadine /economics /therapeutic use; Antiviral Agents /economics /therapeutic use; Cost-Benefit Analysis; Humans; Influenza, Human /drug therapy /economics; Models, Economic; Oseltamivir /economics /therapeutic use; Practice Guidelines as Topic; Premedication; Randomized Controlled Trials as Topic; Seasons; Treatment Outcome; Zanamivir /economics /therapeutic use AccessionNumber 22009101580 Date bibliographic record published 03/06/2009 |
|
|
|